Table 2.
Treatment, n (%) | n = 50 |
---|---|
In situ SRS | 37 (74 %) |
In situ Observed | 5 (10 %) |
Neurosurgery alone | 4 (8 %) |
Cavity SRS | 4 (8 %) |
SRS PTVs, cc | n = 41 |
Mean (SD) | 2.1 (3.3) |
Median [range] | 0.6 [0.0–14.4] |
IQR | 0.3–2.2 |
Missing | 1 |
SRS dose, n (%) | n = 41 |
18Gy in 1 fraction | 3 (7 %) |
20Gy in 1 fraction | 24 (59 %) |
22Gy in 1 fraction | 4 (10 %) |
24Gy in 3 fractions | 9 (22 %) |
30Gy in 5 fractions | 1 (2 %) |